WELL Health Technologies Corp.
WHTCF
$2.71
$0.020.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.50% | 18.06% | 10.62% | 11.60% | 29.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.50% | 18.06% | 10.62% | 11.60% | 29.46% |
| Cost of Revenue | 32.06% | 27.89% | 29.92% | 35.78% | 51.46% |
| Gross Profit | 23.52% | 5.02% | -12.20% | -14.62% | 7.56% |
| SG&A Expenses | 20.75% | 13.90% | 5.55% | 6.61% | 17.38% |
| Depreciation & Amortization | 32.25% | 22.55% | 16.08% | 17.09% | 16.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.30% | 22.71% | 20.09% | 23.35% | 35.25% |
| Operating Income | 45.62% | -189.54% | -238.68% | -240.40% | -71.24% |
| Income Before Tax | -215.74% | -214.05% | -302.49% | -261.77% | 1,519.97% |
| Income Tax Expenses | 62.74% | -120.09% | -13,107.58% | -1,180.37% | -635.14% |
| Earnings from Continuing Operations | -187.61% | -195.91% | -230.91% | -101.00% | 1,226.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 227.65% | 152.90% | 164.81% | 170.93% | -1.18% |
| Net Income | -178.14% | -200.33% | -271.93% | 6,424.72% | 811.72% |
| EBIT | 45.62% | -189.54% | -238.68% | -240.40% | -71.24% |
| EBITDA | 31.61% | -36.32% | -81.76% | -91.90% | -22.92% |
| EPS Basic | -177.38% | -199.83% | -268.24% | 1,374.07% | 848.37% |
| Normalized Basic EPS | 22.19% | -66.74% | -163.41% | -234.43% | -195.77% |
| EPS Diluted | -188.20% | -204.49% | -303.18% | 376.47% | 695.70% |
| Normalized Diluted EPS | 19.92% | -70.81% | -165.58% | -230.80% | -189.86% |
| Average Basic Shares Outstanding | 0.27% | 0.88% | 1.26% | 1.66% | 4.61% |
| Average Diluted Shares Outstanding | -0.86% | -0.64% | 1.14% | 3.68% | 6.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |